Evidence map›Paper›PMID 33352780›Full record

ReviewCancers2020

Cancer Chemotherapy Related Cognitive Impairment and the Impact of the Alzheimer's Disease Risk Factor

Harvey R Fernandez, Ashima Varma, Sarah A Flowers, George William Rebeck

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Cognitive dysfunction in chemobrain: Molecular mechanisms and therapeutic implications.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Chemotherapy-related cognitive impairment and kidney dysfunction.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Review
  12. Article
  13. Review
  14. Review
  15. Seeing through "brain fog": neuroimaging assessment and imaging biomarkers for cancer-related cognitive impairments.Cancer imaging : the official publication of the International Cancer Imaging Society · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Harvey R FernandezDepartment of Neuroscience, Georgetown University, Washington, DC 20057, USA.
Ashima VarmaDepartment of Neuroscience, Georgetown University, Washington, DC 20057, USA.
Sarah A FlowersDepartment of Neuroscience, Georgetown University, Washington, DC 20057, USA.
George William RebeckDepartment of Neuroscience, Georgetown University, Washington, DC 20057, USA.ORCID 0000-0001-6276-248X
Georgetown University · US

Funding

APOE4 promotes pathogenesis in a mouse model of cancer chemotherapy-induced cognitive impairmentR01AG067258 · NIA · GEORGETOWN UNIVERSITY · PI REBECK, G WILLIAM · 2020 to 2024
$2.1M
NIA NIH HHS R01 AG067258
6 · The paper itself

Abstract

Cancer related cognitive impairment (CRCI) is a serious impairment to maintaining quality of life in cancer survivors. Cancer chemotherapy contributes to this condition through several potential mechanisms, including damage to the blood brain barrier, increases in oxidative stress and inflammation in the brain, and impaired neurogenesis, each of which lead to neuronal dysfunction. A genetic predisposition to CRCI is the E4 allele of the Apolipoprotein E gene (

Indexed as

Alzheimer’s diseaseAPOEApolipoprotein Eblood brain barrierchemotherapycognitive impairmentinflammationneurogenesis

Identifiers

PMID33352780
PMCPMC7766535
OpenAlexW3114135310

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.